Similarly, lower TOX expression is also correlated with poor prognosis in brain glioma, brain astrocytoma, breast cancer, and skin melanoma, while only bladder transitional cell carcinoma shows opposite trend. This evidence concerns the gene TOX and bladder transitional cell carcinoma.